Abstract:Objective Alveolar macrophages (AMs) are critical for maintaining the homeostasis of pulmonary microenvironment. They process surfactants to ensure alveoli patency, and also serve as the first line of immune defense against pathogen invasion. Available studies have shown that monocyte-derived AMs continuously release pro-inflammatory cytokines and chemokines, recruiting other immune cells to the damaged area during pulmonary fibrosis. These monocyte-derived AMs maintains and amplifies inflammation, playing a negative role in pulmonary fibrosis progression. Current researches have predominantly focused on the gene expression levels of AMs in pulmonary fibrosis microenvironment, with less emphasis on the function and regulation of proteins. This study aims to investigate the differentially expressed proteins (DEPs) of AMs under normal physiological conditions and after pulmonary fibrosis, in order to gain a more comprehensive understanding of the role of AMs in the progression of pulmonary fibrosis. Methods Firstly, the construction of bleomycin-induced pulmonary fibrosis mouse models was evaluated through using measurements such as body mass, lung coefficient, lung wet-to-dry mass ratio, H&E staining and Masson staining. Subsequently, AMs from both the saline controls and the pulmonary fibrosis models (2.5x10(5) cells per sample) were collected using FACS sorting, and protein expression profiles of these cells were obtained through label-free proteomics approach. The quality of the proteomic data was assessed by comparing our saline control proteomic data with public proteomic data of physiological AMs. Thirdly, DEPs analysis between the saline controls and the bleomycin groups was carried out using R package Prostar. Functional enrichment analyses of significantly upregulated DEPs were performed using R package Clusterprofiler for GO and KEGG pathways. Finally, the STRING database was used to explore the protein-protein interaction networks related to phagocytosis regulation, inflammatory response regulation, and I-xB/NF-xB signaling pathway. The expression levels of Tlr2 and Pycard were detected respectively by FACS and western blotting. Results Compared to the saline controls, mice in the bleomycin groups exhibited a lower average body mass, extensive infiltration of inflammatory cells, and deposition of collagen in the lungs. This indicates that bleomycin successfully induced pulmonary fibrosis in mouse models. The proteomic data of AMs obtained from these models was of high quality and fulfilled the research requirements. A comprehensive analysis showed that 778 proteins were upregulated in pulmonary fibrosis groups compared with control groups. Moreover, the signal pathways enriched in up-regulated DEPs were related to the I-xB/NF-xB pathway, inflammatory response regulation, phagocytosis regulation, TGF-beta signaling, and HIF-1 pathway, indicating that AMs in pulmonary fibrosis microenvironment exerted pro-inflammatory and pro-fibrotic functions. Protein- protein interaction network analysis of the DEPs suggested that the interactions between Tlr2 and Pycard were control nodes for the pro-inflammatory phenotype of AMs, thereby contributing to pulmonary fibrosis progression. Further validation by FACS and Western blotting respectively confirmed that the expression levels of Tlr2 and Pycard in AMs were significantly increased after pulmonary fibrosis. Conclusion This study investigates the changes in the protein expression profile of AMs in the pulmonary fibrosis microenvironment. The results show that AMs notably enhanced the activity of various pathways associated with inflammation and fibrosis, suggesting that the interaction between Tlr2 and Pycard serves as a key control node for the highly pro- inflammatory behavior of AMs.

[Changes of Extracellular Matrix Components in Bronchoalveolar Lavage Fluid in Patients with Idiopathic Pulmonary Fibrosis].

[Changes of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in the Bronchoalveolar Lavage Fluid and the Serum of Patients with Idiopathic Pulmonary Fibrosis].

Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?

Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease

Correlation Between Serum LN, Ⅳ C, P Ⅲ NP, HA and the Severity As Well As the Prognosis of Idiopathic Pulmonary Fibrosis

Determination of Serum Fibrosis Indexes in Patients with Chronic Hepatitis and Its Significance

Extracellular Matrix Remodeling in Children with Airway Foreign‐body Aspiration

[Expressions of Caveolin-1 and Extracellular Matrix in Lung Tissues of Patients with Idiopathic Pulmonary Fibrosis].

Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation

Determination of the Platelet Activating Factor in Silicotic Patients and Its Effect on Fibroblasts

The correlation between serum levels of laminin, type IV collagen, type III procollagen N-terminal peptide and hyaluronic acid with the progression of post-COVID-19 pulmonary fibrosis

Changes of Keratinocyte and Hepatocyte Growth Factor Contents in Bronchoalveolar Lavage Fluid and Serum in Patients with Acute Lung Injury

[Role of Fibronectin in Rat Pulmonary Fibrosis].

Airway inflammation and macrophage inflammatory protein-1α, gelatinase B level in patients with COPD

Research progress of biomarkers in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis

Tuberculosis complicated by fibrosis:detection of bronchial lavage fluid and matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1

Proteomic Analysis of Alveolar Macrophages in Pulmonary Fibrosis Microenvironment

SERUM CONCENTRATIONS OF HYALURONIC ACID, PROCOLLAGEN TYPE III NH 2 -TERMINAL PEPTIDE, AND LAMININ IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE

Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD

The Characteristics and Clinical Significance of Mucin Levels in Bronchoalveolar Lavage Fluid of Patients with Interstitial Lung Disease.

CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity